Prostate cancer recurrence after surgery is nearly double in smokers
the ONA take:
New research points out another cancer prognosis worsened by smoking. This research from an international group of scientists and clinicians from the United States and Europe found that current smokers and those who quit less than 10 years previously are at higher risk of prostate cancer recurrence after surgery.
The group retrospectively reviewed biochemical prostate cancer recurrence in 7,191 men who had undergone radical prostatectomy.
Among the men, approximately one-third each were never smokers, former smokers, and current smokers. After a median follow-up of 28 months, current smokers had approximately double the chance of the cancer recurring. Those who had quit within the last 10 years had a significantly higher risk.
The researchers report that their results confirm what is seen in many other cancers: smoking increases the risk of recurrence after initial treatment.
Furthermore, they recommend that patients stop smoking after a diagnosis of prostate cancer is determined.
Current smokers and those who quit less than 10 years previously are at higher risk of prostate cancer recurrence after surgery.
Sign Up for Free e-newsletters
- Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- Alternate Dosing of Ruxolitinib May Alleviate Anemia in Myelofibrosis
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- Combined Digital Screening Best for Detecting Breast Cancers
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Seeking Reliable Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Oral Hydration Effectively Reduced Risk of Nephrotoxity After Cisplatin
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- The Efficacy and Tolerance of High Pressure Oxygen Combined With Chemotherapy in Postoperative Patients With Advanced Gastric Cancer
- Hepatocellular Cancer Pain: Impact and Management Challenges
- Serum Albumin May Indicate Prognosis for Survival in Acute Myeloblastic Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|